subcutaneous infusion
Showing 1 - 25 of >10,000
Pulmonary Arterial Hypertension Trial in Montreal (Lidocaine, Placebo)
Terminated
- Pulmonary Arterial Hypertension
- Lidocaine
- Placebo
-
Montreal, Quebec, CanadaJewish General Hospital
Jan 30, 2023
ABBV-951 Subcutaneous Infusion to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Oct 25, 2023
Subcutaneous Infusion of ABBV-951 to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Jun 15, 2023
Type2diabetes Trial in Nanning (Henagliflozin, Continuous Subcutaneous Insulin Infusion)
Not yet recruiting
- Type2diabetes
- Henagliflozin
- Continuous Subcutaneous Insulin Infusion
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Jan 9, 2023
Personality and Quality of Life Amelioration After Continuous
Not yet recruiting
- Parkinson Disease
- Continuous subcutaneous apomorphine infusion (CSAI)
-
Bron, France
- +9 more
Oct 17, 2023
Septic Shock, Critical Illness Trial in Damanhur Shubra (Heparin Infusion, subcutaneous heparin)
Completed
- Septic Shock
- Critical Illness
- Heparin Infusion
- subcutaneous heparin
-
Damanhūr Shubrā, Egyptamira Bisher kassem
Dec 18, 2022
Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)
Active, not recruiting
- Diabetes Mellitus, Type 1
- AT247
- +2 more
-
Chula Vista, CaliforniaProSciento, Inc
Aug 12, 2022
Pulmonary Hypertension Due to Left Heart Disease Trial in Neu-Ulm (BAY2701250 IV, Placebo IV, BAY2701250 SC)
Recruiting
- Pulmonary Hypertension Due to Left Heart Disease
- BAY2701250 IV
- +3 more
-
Neu-Ulm, Bayern, GermanyNUVISAN GmbH Neu-Ulm
Sep 19, 2023
Diabetes, Type 1, Type 1 Diabetes Trial in Escondido (coil-reinforced soft polymer indwelling cannula, soft Teflon indwelling
Completed
- Diabetes Mellitus, Type 1
- Type 1 Diabetes
- coil-reinforced soft polymer indwelling cannula
- soft Teflon indwelling catheter
-
Escondido, CaliforniaAMCR Institute
Aug 9, 2022
Type 1 Diabetes, Pregnancy, High Risk Trial in Worcester (Insulin)
Recruiting
- Type 1 Diabetes
- Pregnancy, High Risk
-
Worcester, MassachusettsUniversity of Massachusetts Memorial Medical Center
May 9, 2022
Parkinson Disease Trial (Proactive care pathway)
Not yet recruiting
- Parkinson Disease
- Proactive care pathway
- (no location specified)
Jun 1, 2022
Diabetic Ketoacidosis Trial in Baltimore (Early administration of subcutaneous insulin glargine dose, IV insulin infusion, IV
Completed
- Diabetic Ketoacidosis
- Early administration of subcutaneous insulin glargine dose
- +2 more
-
Baltimore, MarylandUniversity of Maryland Medical Center
Mar 19, 2022
Chronic Heart Failure With Reduced Ejection Fraction Trial in Japan, United States (LY3461767, Placebo)
Recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- LY3461767
- Placebo
-
Detroit, Michigan
- +6 more
Jul 18, 2022
Type 1 Diabetes Trial in Little Rock, Denver, West Des Moines (Insulin aspart SAR341402, Insulin aspart)
Completed
- Type 1 Diabetes Mellitus
- Insulin aspart SAR341402
- Insulin aspart
-
Little Rock, Arkansas
- +2 more
Apr 21, 2022
Healthy Volunteers Trial in Hialeah (TAK-881)
Completed
- Healthy Volunteers
- TAK-881
-
Hialeah, FloridaClinical Pharmacology of Miami
Apr 28, 2022
Type 2 Diabetes, Pregnancy in Diabetic Trial in Beijing (Continuous subcutaneous insulin infusion (CSII), Multiple daily insulin
Not yet recruiting
- Type 2 Diabetes
- Pregnancy in Diabetic
- Continuous subcutaneous insulin infusion (CSII)
- Multiple daily insulin injection (MDI)
-
Beijing, Beijing, ChinaPeking University Third Hospital
Nov 28, 2021
Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)
Completed
- Type 1 Diabetes
- canagliflozin
- basal interruption without canagliflozin
-
New Haven, ConnecticutYale University School of Medicine
Sep 17, 2021
Diabetes, Covid19 Trial in Naples (Continuous glucose monitoring (CGM, Dexcom G6))
Terminated
- Diabetes Mellitus
- Covid19
- Continuous glucose monitoring (CGM, Dexcom G6)
-
Naples, ItalyFederico II University Hospital
Jul 26, 2022
Real-world Data for In-silico Evaluation ofNew Software
Completed
- Diabetes Mellitus, Type 1
- YpsoPump® insulin pump system
-
Ulm, Germany
- +1 more
Mar 21, 2022
Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- HYQVIA
- (no location specified)
Feb 23, 2023
Melanoma Trial in Worldwide (Pembrolizumab Dose C, Pembrolizumab Dose A, Pembrolizumab Dose B)
Active, not recruiting
- Melanoma
- Pembrolizumab Dose C
- +3 more
-
Orange, New South Wales, Australia
- +14 more
Jan 19, 2023
Diabetes Trial in Graz (Continous Subcutaneous Insulin Infusion Catheter)
Recruiting
- Diabetes Mellitus
- Continous Subcutaneous Insulin Infusion Catheter
-
Graz, AustriaDivision of Plastic, Aesthetic and Reconstructive Surgery
Sep 21, 2021